
Biotech Stocks Update: A Review of the Biotech Stocks for the Week
AbbVie (ABBV) was in the news last week thanks to its agreements with Infinity Pharmaceuticals (INFI) and Calico. Keryx Biopharmaceuticals (KERX) was also in the headlines – the company’s shares declined despite receiving FDA approval for its oral, ferric iron-based compound. Gilead (GILD) was in the news as well, once again due to its hepatitis C virus (HCV) treatment, Sovaldi. AbbVie was very active on … Continue reading Biotech Stocks Update: A Review of the Biotech Stocks for the Week